ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TNXP Tonix Pharmaceuticals Holding Corporation

0.4424
-0.0375 (-7.81%)
Dec 06 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Tonix Pharmaceuticals Holding Corporation TNXP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0375 -7.81% 0.4424 19:59:03
Open Price Low Price High Price Close Price Prev Close
0.4899 0.415 0.499 0.4601 0.4799
more quote information »

Recent News

Date Time Source Heading
12/04/202307:10EDGAR2Form 8-K - Current report
12/04/202307:00GLOBETonix Pharmaceuticals Announces IND Clearance by the FDA for..
11/28/202307:00GLOBETonix Pharmaceuticals to Present at Two Upcoming Investor..
11/15/202307:05EDGAR2Form 8-K - Current report
11/15/202307:00GLOBETonix Pharmaceuticals Completes Clinical Stage of Phase 3..
11/13/202307:05EDGAR2Form 8-K - Current report
11/13/202307:00GLOBETonix Pharmaceuticals Announces Enrollment Initiated in Mass..
11/09/202316:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202316:15GLOBETonix Pharmaceuticals Reports Third Quarter 2023 Financial..
11/02/202308:05EDGAR2Form 8-K - Current report
11/02/202308:00GLOBETonix Pharmaceuticals’ Vaccine Candidate, TNX-1800, Selected..
10/31/202317:06EDGAR2Form 8-K - Current report
10/31/202317:00GLOBETonix Pharmaceuticals Announces Topline Results from Phase 2..
10/30/202307:49EDGAR2Form 8-K - Current report
10/30/202307:00GLOBETonix Pharmaceuticals Announces New Data Involving TNX-1500..
10/26/202307:17EDGAR2Form 8-K - Current report
10/26/202307:00GLOBETonix Pharmaceuticals Completes Clinical Stage of Phase 2..
10/20/202317:07EDGAR2Form 8-K - Current report
10/20/202316:53EDGAR2Form PRE 14A - Other preliminary proxy statements
10/19/202307:05EDGAR2Form 8-K - Current report
10/18/202307:05EDGAR2Form 8-K - Current report
10/18/202307:00GLOBETonix Pharmaceuticals Announces Publication of Data in the..
10/16/202316:32EDGAR2Form 8-K - Current report
10/16/202307:05EDGAR2Form 8-K - Current report
10/16/202307:00GLOBETonix Pharmaceuticals Completes Clinical Stage of Phase 2..
10/12/202307:00GLOBETonix Pharmaceuticals to Present at the 2023 ThinkEquity..
10/11/202307:00GLOBETonix Pharmaceuticals Announces Oral Presentation at the..
10/09/202307:00GLOBETonix Pharmaceuticals Provides Overview of TNX-2900 Program..
10/04/202307:05EDGAR2Form 8-K - Current report
10/04/202307:00GLOBETonix Pharmaceuticals Announces Issuance of EU Patent..
9/29/202316:16EDGAR2Form 8-K - Current report
9/29/202316:15EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
9/28/202321:00GLOBETonix Pharmaceuticals Announces Pricing of $4.5 Million..
9/28/202316:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
9/28/202316:01GLOBETonix Pharmaceuticals Announces Proposed Public Offering
9/27/202308:35EDGAR2Form 8-K - Current report
9/27/202308:30GLOBETonix Pharmaceuticals Announces Department of Defense Grant..
9/25/202316:36EDGAR2Form 8-K - Current report
9/21/202307:05EDGAR2Form 8-K - Current report
9/21/202307:00GLOBETonix Pharmaceuticals Presents New Preclinical Data at..
9/18/202308:28EDGAR2Form 8-K - Current report
9/18/202307:00GLOBETonix Pharmaceuticals Announces Presentation of Non-Clinical..
9/15/202309:30GLOBENew to The Street Announces Episodes 510 and 511 Six..
9/14/202309:15EDGAR2Form 8-K - Current report
9/14/202307:00GLOBETonix Pharmaceuticals Announces Poster Presentation..
9/11/202308:31EDGAR2Form 8-K - Current report
9/06/202307:05EDGAR2Form 8-K - Current report
9/06/202307:00GLOBETonix Pharmaceuticals Announces Commitment to Supply..
9/05/202307:07EDGAR2Form 8-K - Current report
9/05/202307:00GLOBETonix Pharmaceuticals Announces Topline Results from Phase 2..

Your Recent History

Delayed Upgrade Clock